27824334|t|Episomal Nonviral Gene Therapy Vectors Slow Progression of Atherosclerosis in a Model of Familial Hypercholesterolemia
27824334|a|Familial hypercholesterolemia (FH) is a life-threatening genetic disorder characterized by elevated levels of plasma low-density lipoprotein cholesterol (LDL-cholesterol). Current attempts at gene therapy for FH have been limited by the use of strong heterologous promoters which lack genomic DNA elements essential for regulated expression. Here, we have combined a mini-gene vector expressing the human LDLR cDNA from a 10 kb native human LDLR locus genomic DNA promoter element, with an efficient miRNA targeting 3-hydroxy-3-methylgutaryl-coenzyme A reductase (Hmgcr), to further enhance LDLR expression. We show that the combined vector suppresses endogenous Hmgcr transcripts in vivo, leading to an increase in LDLR transgene expression. In a diet-induced Ldlr(-/-) mouse model of FH, we show that administration of the combined vector reduces atherogenic plasma lipids by ~32%. Finally, we demonstrate that our episomal nonviral vectors are able to reduce atherosclerosis by ~40% after 12 weeks in vivo. Taken together, the vector system we describe exploits the normal cellular regulation of the LDLR to provide prolonged expression of LDLR through targeted knockdown of Hmgcr. This novel gene therapy system could act alone, or in synergy with current therapies that modulate intracellular cholesterol, such as statins, greatly enhancing its therapeutic application for FH.
27824334	0	8	Episomal	T103	UMLS:C0014587
27824334	9	17	Nonviral	T033	UMLS:C0243095
27824334	18	38	Gene Therapy Vectors	T103	UMLS:C1517498
27824334	39	55	Slow Progression	T033	UMLS:C1854494
27824334	59	74	Atherosclerosis	T038	UMLS:C0004153
27824334	89	118	Familial Hypercholesterolemia	T038	UMLS:C0020445
27824334	119	148	Familial hypercholesterolemia	T038	UMLS:C0020445
27824334	150	152	FH	T038	UMLS:C0020445
27824334	159	175	life-threatening	T033	UMLS:C2826244
27824334	176	192	genetic disorder	T038	UMLS:C0019247
27824334	219	271	levels of plasma low-density lipoprotein cholesterol	T058	UMLS:C1278149
27824334	273	288	LDL-cholesterol	T103	UMLS:C0023824
27824334	311	323	gene therapy	T058	UMLS:C0017296
27824334	328	330	FH	T038	UMLS:C0020445
27824334	383	392	promoters	T103	UMLS:C0035902
27824334	404	415	genomic DNA	T103	UMLS:C3272453
27824334	449	459	expression	T038	UMLS:C0017262
27824334	486	502	mini-gene vector	T103	UMLS:C0017397
27824334	503	513	expressing	T038	UMLS:C0017262
27824334	518	523	human	T204	UMLS:C0086418
27824334	524	528	LDLR	T017	UMLS:C1366529
27824334	529	533	cDNA	T103	UMLS:C0006556
27824334	554	559	human	T204	UMLS:C0086418
27824334	560	564	LDLR	T017	UMLS:C1366529
27824334	565	570	locus	T017	UMLS:C0678933
27824334	571	582	genomic DNA	T103	UMLS:C3272453
27824334	583	591	promoter	T103	UMLS:C0035902
27824334	619	624	miRNA	T103	UMLS:C1101610
27824334	635	681	3-hydroxy-3-methylgutaryl-coenzyme A reductase	T017	UMLS:C1415615
27824334	683	688	Hmgcr	T017	UMLS:C1415615
27824334	710	714	LDLR	T017	UMLS:C1366529
27824334	715	725	expression	T038	UMLS:C0017262
27824334	753	759	vector	T103	UMLS:C0017397
27824334	760	770	suppresses	T038	UMLS:C0038855
27824334	782	787	Hmgcr	T017	UMLS:C1415615
27824334	788	799	transcripts	T103	UMLS:C1519595
27824334	800	807	in vivo	T082	UMLS:C1515655
27824334	835	839	LDLR	T017	UMLS:C1366529
27824334	840	849	transgene	T017	UMLS:C0282641
27824334	850	860	expression	T038	UMLS:C0017262
27824334	880	889	Ldlr(-/-)	T017	UMLS:C1366529
27824334	890	901	mouse model	T204	UMLS:C0206745
27824334	905	907	FH	T038	UMLS:C0020445
27824334	922	936	administration	T058	UMLS:C1533734
27824334	953	959	vector	T103	UMLS:C0017397
27824334	968	993	atherogenic plasma lipids	T058	UMLS:C1278073
27824334	1036	1061	episomal nonviral vectors	T103	UMLS:C0017397
27824334	1081	1096	atherosclerosis	T038	UMLS:C0004153
27824334	1120	1127	in vivo	T082	UMLS:C1515655
27824334	1149	1155	vector	T103	UMLS:C0017397
27824334	1195	1214	cellular regulation	T038	UMLS:C0596286
27824334	1222	1226	LDLR	T017	UMLS:C1366529
27824334	1248	1258	expression	T038	UMLS:C0017262
27824334	1262	1266	LDLR	T017	UMLS:C1366529
27824334	1284	1293	knockdown	T062	UMLS:C2350567
27824334	1297	1302	Hmgcr	T017	UMLS:C1415615
27824334	1315	1327	gene therapy	T058	UMLS:C0017296
27824334	1394	1402	modulate	T082	UMLS:C0443264
27824334	1403	1416	intracellular	T082	UMLS:C0178719
27824334	1417	1428	cholesterol	T103	UMLS:C0008377
27824334	1438	1445	statins	T103	UMLS:C0360714
27824334	1469	1492	therapeutic application	T058	UMLS:C0087111
27824334	1497	1499	FH	T038	UMLS:C0020445